Profit increased in the full fiscal year of 2023 for Danish pharmaceutical company Novo Nordisk compared to the previous year. Novo Nordisk reported on Wednesday that its fiscal 2023 net profit increased to 83.68 billion Danish kroner ($12.15 billion) from 55.52 billion kroner in the prior year. Earnings per share were 18.62 kroner compared to 12.22 kroner. Operating profit increased by 37% in kroner and by 44% at constant exchange rates to 102.6 billion kroner. Fiscal 2023 net sales increased to 232.26 billion kroner from 176.95 billion kroner. Sales were up 31% in Danish kroner and by 36% at…